Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Not going put the cart before the horse but he may very well be part of the “surprise “ that has been mentioned.
I looked that up he’s 68 was looking at his bio so maybe health reasons maybe not something they are not going to share either way.
Sorry if already posted by someone
Current Short Volume11,910,000 shares
Previous Short Volume10,170,000 shares
Change Vs. Previous Month+17.11%
Dollar Volume Sold Short$105.05 million
Short Interest Ratio / Days to Cover6.0
Last Record DateNovember 30, 2022
Yahoo shows $12.05.
Oh my god that makes me laugh ??!!! ??.
Saw him post tonight on the Yahoo board.
No, just looking for results had forgotten about the jabs about shiny bikes, ya made me chuckle.
Been lurking and don’t post but I can’t say I’ve ever felt this anxious to see what the results are as much as I feel confident it’s positive kinda like Christmas as a kid lol.
Can you copy and paste it they want you to get a subscription, not a fan of providing personal info for one article.
Thank you appreciate the guidance. Wondered about the one for the end of June, I’ll take a look.
Does anyone know when they actually publish the shares short. I realize the data is from the 15th & 30th (approx.) of each month and I thought ok a holiday weekend it would be Tuesday or Wednesday. Still isn’t available, anyone familiar with the time line they usually follow? TIA.
When pressure builds from other sources to get it approved as is exactly the case with BIIB - ALZ society etc the FDA will eventually do it.
And this is why TGD has utilized areas outside of the FDA grasp, slowed it probably, stop it not a chance.
My sentiments exactly!!!
Could catch a homer as well and that kinda how I feel I have no direct involvement in the game research or trials but I’m supporting my team by investing. If they can hit out of the park and my investment grows fantastical I just caught that homer!!!
And let’s not forget the poison pill that shareholders authorized!!!
Is anyone aware of which style of poison pill the company is utilizing?
What's a Flip-In Poison Pill?
A flip-in poison pill strategy involves allowing the shareholders, except for the acquirer, to purchase additional shares at a discount. Though purchasing additional shares provides shareholders with instantaneous profits, the practice dilutes the value of the limited number of shares already purchased by the acquiring company. This right to purchase is given to the shareholders before the takeover is finalized and is often triggered when the acquirer amasses a certain threshold percentage of shares of the target company.
What's a Flip-Over Poison Pill?
A flip-over poison pill strategy allows stockholders of the target company to purchase the shares of the acquiring company at a deeply discounted price if the hostile takeover attempt is successful. For example, a target company shareholder may gain the right to buy the stock of its acquirer at a two-for-one rate, thereby diluting the equity in the acquiring company. The acquirer may avoid going ahead with such acquisitions if it perceives a dilution of value post-acquisition.
Missling went after the poison pill not once but twice, the longs will remember this. The poison pill and the additional shares are tactically the best way to thwart off an unwanted take over attempt.
Wonder if the current uptick in price could be the result of the presentation this morning?
Over 424 K
Exactly what’s taking place, they are gonna ride it up and down to make their perceived due. Then and under their control will we see what we are know is the actual value per share.
From the Yahoo board -
FDA Adviser Said To Quit Over Approval Of Biogen's Alzheimer's Drug His Expert Panel Doubted
01:07 PM EDT, 06/09/2021 (MT Newswires) -- A member of the US Food and Drug Administration's expert panel for nervous system therapies stepped down from his post Monday following the regulator's approval of Biogen's (BIIB) Alzheimer's therapy Aduhelm, Stat News reported Tuesday.
Joel Perlmutter, a member of the advisory committee that recommended against approval of the drug, told Stat in an email that his resignation was "due to this ruling by the FDA without further discussion with our advisory committee," according to the medical news site.
In the November 2020 advisory voting, 10 of 11 FDA panelists found there was not enough evidence that Aduhelm is effective in slowing cognitive decline caused by Alzheimer's while one voted "uncertain," according to the report. However, the FDA still approved the treatment Monday.
While the FDA is not required to follow its advisory committees' recommendations, in the past "overrulings generally came when the votes were closer," Stat News said.
You have hit the nail on the head, absolutely correct, this was exactly what Dr. M was saying when asked about Biogens drug and meeting with the FDA any potential approval and how it would impact AV.
As much as I liked the pre & post market activity when the shares were headed toward $28 the .89 climb this morning is only 5 shares and there has been less than 500 shares traded this morning.
I’ll assume you are aware the labs aspect is going to be producing product in Q2. The margins of those items I understand are very good which would be a major source of revenue towards profitability.
I had the thought that the wheels were established and in motion when he went there. So my thought was ok this has been examined extensively, not gonna stir the pot in my new digs so let it take its natural course and let it die a natural death. Then once they are open to and now in need of a new direction let’s look over here my, my what does this do, AV is the right fit.
Agree whole heartedly.
Whisky Sausage that’s a name I hadn’t heard in a while.
It certainly looks like there is a desire to keep the share price $16 or under, is there a group who have an order to fill?
Been here pre split remember being quite peeved that my 44,000 got restructured to just 11,000. Like some I don’t post all that often.
Watching the trading today it certainly appears that there is a desire to keep this under $15.......???
TGD has stated he would “partner” I believe his word, he intends to remain in the drivers seat of how the pipeline of the company unfolds. He didn’t put a poison pill in place just to take a lucrative deal it was to maintain the company as an entity IMO.
Trading kinda like it did yesterday hit the daily high over lunch then dropped back where it climbed near the end of the day. Will we see a repeat???
Certainly looks like some stability in the share price at this level, so far after hours trades have been $13.48-$13.50 with over 17,500 traded.
With the buy out discussion being brought up & even if it was at an “over inflated” value, AV did not try once, but twice to get the poison pill into place. The Dr. has made it clear he will partner, he doesn’t want some big dollar paying entity to shelve all the hard work. There is no better way than to hold big Pharma’s feet to the fire than have them as a jr partner which will most likely for some cut off or diminish at least some of their current revenue stream. There is also the phrase just when you think you’ve seen it all....bam anything is possible!!!
There are powers that be who don’t want this higher than it is $15 which is where they are gonna try & keep it.
If memory serves me correctly AV presented at the Oppenheimer conference last year.
I’m just trying to understand how the various different channels would work. New deals will benefit us that’s clear but I just read yesterday Suagerbud just did I a deal with OCS (Ontario Cannabis) so if they have deals with both do we get any benefit when sold in Ontario through OCS?
I shouldn’t think that’s overly surprising considering who he’s employed by and the direction that they are leaning.
I agree although he didn’t put it in those words his reference to other trials was made and he may have been vague on purpose as to not have the line in the sand and then an unexpected delay comes into play. Once he has the pieces in place then makes the announcement.